Redox regulation of CD21 shedding involves signaling via PKC and indicated the formation of a juxtamembrane stalk

Journal of Cell Science

Volumn 119, Issue 14, 2006, Pages 2892-2902

  Aichem, Annette ^a   Masilamani, Madhan ^b,c   Illges, Harald ^a,b,d  

^a UNIVERSITY OF KONSTANZ   (Switzerland)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

B cells; CD21; Cell activation; Complement receptor; Diselenide bridge; Redox potential; Selenocysteine

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; B LYMPHOCYTE RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; CYSTEINE; DISULFIDE; GLUTATHIONE; METALLOPROTEINASE; METHIONINE; PERVANADATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SELENOCYSTEINE; SERINE; THIOL;

AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL MEMBRANE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEMBRANE STRUCTURE; MONOCYTE; OXIDATION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN SECRETION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 33745279211     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02984     Document Type: Article

References (54)

1. Ahearn, J. M., Fischer, M. B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R. G., Rothstein, T. L. and Carroll, M. C. (1996). Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251-262.
2. Althoff, K., Mullberg, J., Aasland, D., Voltz, N., Kallen, K., Grotzinger, J. and Rose-John, S. (2001). Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem. J. 353, 663-672.
3. Arribas, J. and Merlos-Suárez, A. (2003). Shedding of plasma membrane proteins. In Current Topics in Developmental Biology: Cell Surface Proteases. Vol. 54 (ed. S. Zucker and W. T. Chen), pp. 125-144. London: Academic Press.
4. Arribas, J., Lopez-Casillas, F. and Massague, J. (1997). Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. J. Biol. Chem, 272, 17160-17165.
5. Bacon, K., Gauchat, J. F., Aubry, J. P., Pochon, S., Graber, P., Henchoz, S. and Bonnefoy, J. Y. (1993). CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD21 antibodies. Eur. J. Immunol. 23, 2721-2724.
6. Besse, D. and Moroder, L. (1997). Synthesis of selenocysteine peptides and their oxidation to diselenide-bridged compounds. J. Pept. Sci. 3, 442-453.
7. Besse, D., Budisa, N., Karnbrock, W., Minks, C., Musiol, H. J., Pegoraro, S., Siedler, F., Weyher, E. and Moroder, L. (1997). Chalcogen-analogs of amino acids. Their use in x-ray crystallographic and folding studies of peptides and proteins. Biol. Chem. 378, 211-218.
8. Buhimschi, I. A., Kramer, W. B., Buhimschi, C. S., Thompson, L. P. and Weiner, C. P. (2000). Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am. J. Obstet. Gynecol. 182, 458-464.
9. Carel, J. C., Frazier, B., Ley, T. J. and Holers, M. (1989). Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells. J. Immunol. 143, 923-930.
10. De Vries, N. and De Flora, S. (1993). N-acetyl-1-cysteine. J. Cell. Biochem. Suppl. 17F, 270-277.
11. Delibrias, C. C., Mouhoub, A., Fischer, E. and Kazatchkine, M. D. (1994). CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur. J. Immunol. 24, 2784-2788.
12. Dello Sbarba, P. and Rovida, E. (2002). Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol. Chem. 383, 69-83.
13. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A. and Fearon, D. T. (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81, 4510-4514.
14. Fingeroth, J. D., Diamond, M. E., Sage, D. S., Hayman, J. and Yates, J. L. (1999). CD21-dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J. Virol. 73, 2115-2125.
15. Fischer, E., Delibrias, C. and Kazatchkine, M. D. (1991). Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146, 865-869.
16. Fischer, M. B., Goerg, S., Shen, L., Prodeus, A. P., Goodnow, C. C., Kelsoe, G. and Carroll, M. C. (1998). Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280, 582-585.
17. Fremeaux-Bacchi, V., Aubry, J. P., Bonnefoy, J. Y., Kazatchkine, M. D., Kolb, J. P. and Fischer, E. M. (1998). Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23. Eur. J. Immunol. 28, 4268-4274.
18. Fujisaku, A., Harley, J. B., Frank, M. B., Gruner, B. A., Frazier, B. and Holers, V. M. (1989). Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J. Biol. Chem. 264, 2118-2125.
19. Gasque, P., Chan, P., Mauger, C., Schouft, M. T., Singhrao, S., Dierich, M. P., Morgan, B. P. and Fontaine, M. (1996). Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156, 2247-2255.
20. Hooper, N. M., Karran, E. H. and Turner, A. J. (1997). Membrane protein secretases. Biochem. J. 321, 265-279.
21. Huemer, H. P., Larcher, C., Prodinger, W. M., Petzer, A. L., Mitterer, M. and Falser, N. (1993). Determination of soluble CD21 as a parameter of B cell activation. Clin. Exp. Immunol. 93, 195-199.
22. Janatova, J., Reid, K. B. and Willis, A. C. (1989). Disulfide bonds are localized within the short consensus repeat units of complement regulatory proteins: C4b-binding protein. Biochemistry 28, 4754-4761.
23. Kaup, M., Dassler, K., Weise, C. and Fuchs, H. (2002). Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2. J. Biol. Chem. 277, 38494-38502.
24. Krol, A. (2002). Evolutionarily different RNA motifs and RNA-protein complexes to achieve selenoprotein synthesis. Biochimie 84, 765-774.
25. Le Gall, S. M., Auger, R., Dreux, C. and Mauduit, P. (2003). Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J. Biol. Chem. 278, 45255-45268.
26. Leonard, J. L., Leonard, D. M., Shen, Q., Farwell, A. P. and Newburger, P. E. (1996). Selenium-regulated translation control of heterologous gene expression: normal function of selenocysteine-substituted gene products. J. Cell Biochem. 61, 410-419.
27. Ling, N., Hansel, T., Richardson, P. and Brown, B. (1991). Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia. Clin. Exp. Immunol. 84, 16-22.
28. Lowe, J., Brown, B., Hardie, D., Richardson, P. and Ling, N. (1989). Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia. Immunol. Lett. 20, 103-109.
29. Masilamani, M., Apell, H. J. and Illges, H. (2002). Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation. J. Immunol. Methods 270, 11-18.
30. Masilamani, M., Kassahn, D., Mikkat, S., Glocker, M. O. and Illges, H. (2003a). B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur. J. Immunol. 33, 2391-2397.
31. Masilamani, M., von Kempis, J. and Illges, H. (2003b). Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis. Rheumatology Oxford 43, 186-190.
32. Masilamani, M., Nowack, R., Witte, T., Schlesier, M., Warnatz, K., Glocker, M. O., Peter, H. H. and Illges, H. (2004). Reduction of soluble complement receptor II/CD21 in systemic lupus erythomatosus and Sjoegren's syndrome but not juvenile arthritis. Scand. J. Immunol. 60, 625-630.
33. Migaki, G. I., Kahn, J. and Kishimoto, T. K. (1995). Mutational analysis of the membrane-proximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site. J. Exp. Med. 182, 549-557.
34. Moore, M. D., Cooper, N. R., Tack, B. F. and Nemerow, G. R. (1987). Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 84, 9194-9198.
35. Muller, C., Wingler, K. and Brigelius-Flohe, R. (2003). 3′UTRs of glutathione peroxidases differentially affect selenium-dependent mRNA stability and selenocysteine incorporation efficiency. Biol. Chem. 384, 11-18.
36. Muller, S., Senn, H., Gsell, B., Vetter, W., Baron, C. and Bock, A. (1994). The formation of diselenide bridges in proteins by incorporation of selenocysteine residues: biosynthesis and characterization of (Se)2-thioredoxin. Biochemistry 33, 3404-3412.
37. Myones, B. L. and Ross, G. D. (1987). Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site. Complement 4, 87-98.
38. Nishinaka, Y., Nakamura, H., Okada, N., Okada, H. and Yodoi, J. (2001). Redox control of EBV infection: prevention by thiol-dependent modulation of functional CD21/EBV receptor expression. Antioxid. Redox Signal. 3, 1075-1087.
39. Perkins, S. J., Gilbert, H. E., Aslam, M., Hannan, J., Holers, V. M. and Goodship, T. H. (2002). Solution structures of complement components by x-ray and neutron scattering and analytical ultracentrifugation. Biochem. Soc. Trans. 30, 996-1001.
40. Qin, D., Wu, J., Carroll, M. C., Burton, G. F., Szakal, A. K. and Tew, J. G. (1998). Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161, 4549-4554.
41. Reth, M. (2002). Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3, 1129-1134.
42. Reynes, M., Aubert, J. P., Cohen, J. H., Audouin, J., Tricottet, V., Diebold, J. and Kazatchkine, M. D. (1985). Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immunol. 135, 2687-2694.
43. fyn tyrosine kinases in human lymphocytes. Blood 82, 1212-1220.
44. Schwab, J. and Illges, H. (2001). Regulation of CD21 expression by DNA methylation and histone deacetylation. Int. Immunol. 13, 705-710.
45. Siedler, F., Rudolph-Bohner, S., Doi, M., Musiol, H. J. and Moroder, L. (1993). Redox potentials of active-site bis(cysteinyl) fragments of thiol-protein oxidoreductases. Biochemistry 32, 7488-7495.
46. Steiner, D. F., Smeekens, S. P., Ohagi, S. and Chan, S. J. (1992). The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267, 23435-23438.
47. Tedder, T. F., Clement, L. T. and Cooper, M. D. (1984). Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133, 678-683.
48. Uckun, F. M., Tuel-Ahlgren, L., Song, C. W., Waddick, K., Myers, D. E., Kirihara, J., Ledbetter, J. A. and Schieven, G. L. (1992). Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. Proc. Natl. Acad. Sci. USA 89, 9005-9009.
49. Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., Harrison, D. G. and Tsao, P. S. (2001). Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88, 1291-1298.
50. Van Wart, H. E. and Birkedal-Hansen, H. (1990). The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87, 5578-5582.
51. Velasco-Loyden, G., Arribas, J. and Lopez-Casillas, F. (2004). The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J. Biol. Chem. 279, 7721-7733.
52. Weis, J. J., Tedder, T. F. and Fearon, D. T. (1984). Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 81, 881-885.
53. Weis, J. J., Toothaker, L. E., Smith, J. A., Weis, J. H. and Fearon, D. T. (1988). Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/ C4 binding proteins. J. Exp. Med. 168, 1953-1954.
54. Zucker, S., Pei, D., Cao, J. and Lopez-Otin, C. (2003). Membrane type-matrix metalloproteinases (MT-MMP). In Current Topics in Developmental Biology: Cell Surface Proteases. Vol. 54 (ed. S. Zucker and W. T. Chen), pp. 1-74. London: Academic Press.